![Timothy Kieffer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Kieffer
Directeur Technique/Scientifique/R&D chez
AARDVARK THERAPEUTICS, INC.
Profil
Timothy Kieffer is Chief Scientific Officer at Aardvark Therapeutics, Inc. since 2025.
Formerly, Dr. Kieffer was Chief Scientific Officer at Fractyl Health, Inc., Chief Scientific Officer at ViaCyte, Inc. from 2021 to 2022, and Professor at the University of British Columbia.
Dr. Kieffer earned a doctorate from the University of British Columbia.
Postes actifs de Timothy Kieffer
| Sociétés | Poste | Début |
|---|---|---|
| AARDVARK THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 20/05/2025 |
Anciens postes connus de Timothy Kieffer
| Sociétés | Poste | Fin |
|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Directeur Technique/Scientifique/R&D | 01/10/2022 |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| FRACTYL HEALTH, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Timothy Kieffer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
23
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fractyl Health, Inc.
 Fractyl Health, Inc. BiotechnologyHealth Technology Develops and sells therapeutics for metabolic diseases, type 2 diabetes & obesity | Health Technology |
Aardvark Therapeutics, Inc.
 Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases | Health Technology |
